Advanced glycation end-products suppress neuropilin-1 expression in podocytes.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Kidney International

• Publication date

  2009-03-02

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/ki.2008.603PMID 19037249
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Semaphorin3a disrupts podocyte foot processes causing acute proteinuria.

  2008cited by this paper
• Serum Levels of the Advanced Glycation End Products Nε-Carboxymethyllysine and Pentosidine Are Not Influenced by Treatment with the Angiotensin Receptor II Type 1 Blocker Irbesartan in Patients with Type 2 Diabetic Nephropathy and Hypertension

  2008cited by this paper
• Advanced glycation end-products induce cell cycle arrest and hypertrophy in podocytes.

  2008cited by this paper
• Semaphorin-3A guides radial migration of cortical neurons during development

  2008cited by this paper
• Cellular and Molecular Mechanisms of Proteinuria in Diabetic Nephropathy

  2007cited by this paper
• Inhibiting albumin glycation attenuates dysregulation of VEGFR-1 and collagen IV subchain production and the development of renal insufficiency.

  2007cited by this paper
• Collagen type VIII expression in human diabetic nephropathy

  2007cited by this paper
• Neuropilins in physiological and pathological angiogenesis

  2007cited by this paper
• Podocytes in culture: past, present, and future.

  2007cited by this paper
• No Change in Glomerular Heparan Sulfate Structure in Early Human and Experimental Diabetic Nephropathy*

  2006cited by this paper
• Autocrine class 3 semaphorin system regulates slit diaphragm proteins and podocyte survival.

  2006cited by this paper
• The podocyte's response to injury: role in proteinuria and glomerulosclerosis.

  2006cited by this paper
• Advanced glycation end products inhibit tubulogenesis and migration of kidney epithelial cells in an ezrin-dependent manner.

  2006cited by this paper
• Autocrine VEGF-A system in podocytes regulates podocin and its interaction with CD2AP.

  2006cited by this paper
• The Advanced Glycation End Product Nε-Carboxymethyllysine Is Not a Predictor of Cardiovascular Events and Renal Outcomes in Patients With Type 2 Diabetic Kidney Disease and Hypertension

  2006cited by this paper
• Vascular endothelial growth factor a signaling in the podocyte-endothelial compartment is required for mesangial cell migration and survival.

  2006cited by this paper
• The advanced glycation end product N(epsilon)-carboxymethyllysine is not a predictor of cardiovascular events and renal outcomes in patients with type 2 diabetic kidney disease and hypertension.

  2006cited by this paper
• Advanced glycation end products and diabetic nephropathy.

  2005cited by this paper
• Advanced glycation end products and the kidney.

  2005cited by this paper
• Advanced glycation end products and the kidney

  2005cited by this paper
• Podocyte depletion causes glomerulosclerosis: diphtheria toxin-induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene.

  2005cited by this paper
• From the periphery of the glomerular capillary wall toward the center of disease: podocyte injury comes of age in diabetic nephropathy.

  2005cited by this paper
• Advanced glycation end product ligands for the receptor for advanced glycation end products: biochemical characterization and formation kinetics.

  2004cited by this paper
• RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy.

  2003cited by this paper
• Functional evidence that vascular endothelial growth factor may act as an autocrine factor on human podocytes.

  2003cited by this paper
• Terminal differentiation of human epidermal keratinocytes involves mitochondria- and caspase-dependent cell death pathway

  2003cited by this paper
• Abnormal lymphatic vessel development in neuropilin 2 mutant mice.

  2002cited by this paper
• Ontogeny of semaphorins 3A and 3F and their receptors neuropilins 1 and 2 in the kidney.

  2002cited by this paper
• Quantitative gene expression analysis in renal biopsies: a novel protocol for a high-throughput multicenter application.

  2002cited by this paper
• Neuropilins as Semaphorin receptors: in vivo functions in neuronal cell migration and axon guidance.

  2002cited by this paper
• Ontogeny of semaphorins 3A and 3F and their receptors neuropilins 1 and 2 in the kidney.

  2002cited by this paper
• Targeting of both mouse neuropilin-1 and neuropilin-2 genes severely impairs developmental yolk sac and embryonic angiogenesis

  2002cited by this paper
• Podocyte Injury Promotes Progressive Nephropathy in Zucker Diabetic Fatty Rats

  2002cited by this paper
• VEGF165 mediates formation of complexes containing VEGFR‐2 and neuropilin‐1 that enhance VEGF165‐receptor binding

  2002cited by this paper
• Role of neuropilins and semaphorins in angiogenesis and cancer.

  2002cited by this paper
• Inhibiting albumin glycation in vivo ameliorates glomerular overexpression of TGF-beta1.

  2002cited by this paper
• Expression of neuropilin-1 by human glomerular epithelial cells in vitro and in vivo.

  2001cited by this paper
• Role of mesangial expansion in the pathogenesis of diabetic nephropathy.

  2001cited by this paper
• Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

  2001cited by this paper
• Monocyte chemoattractant protein-1 and osteopontin differentially regulate monocytes recruitment in experimental glomerulonephritis.

  2001cited by this paper
• The interaction of neuropilin-1 with vascular endothelial growth factor and its receptor flt-1.

  2000cited by this paper
• Course of renal function in type 2 diabetic patients with abnormalities of albumin excretion rate.

  2000cited by this paper
• Glomerular expression of p27Kip1 in diabetic db/db mouse: role of hyperglycemia.

  1998cited by this paper
• Progression of glomerular diseases: is the podocyte the culprit?

  1998cited by this paper
• Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor.

  1998cited by this paper
• Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines.

  1997cited by this paper
• Evolution of renal function abnormalities in the db/db mouse that parallels the development of human diabetic nephropathy.

  1996cited by this paper
• Glycation and Diabetic Complications

  1994cited by this paper
• Lilly Lecture 1993. Glycation and diabetic complications.

  1994cited by this paper
• Angiotensin II stimulates the proliferation and biosynthesis of type I collagen in cultured murine mesangial cells.

  1992cited by this paper
• Characterization of a renal tubular epithelial cell line which secretes the autologous target antigen of autoimmune experimental interstitial nephritis

  1988cited by this paper

• Advanced Glycation End Products Mediate Epigenetic Alteration of H3K27me3 in Renal Proximal Tubular Cells: Potential Role in Metabolic Memory

  2025cites this paper
• Potential Effects of Hyperglycemia on SARS-CoV-2 Entry Mechanisms in Pancreatic Beta Cells

  2024cites this paper
• The Functions of SARS-CoV-2 Receptors in Diabetes-Related Severe COVID-19

  2024cites this paper
• Role of Epigenetic Changes in the Pathophysiology of Diabetic Kidney Disease

  2024cites this paper
• SiJunZi decoction ameliorates bone quality and redox homeostasis and regulates advanced glycation end products/receptor for advanced glycation end products and WNT/β-catenin signaling pathways in diabetic mice.

  2023cites this paper
• The role of advanced glycation end products in patogenesis of diabetic nephropathy

  2022cites this paper
• Neuropilin (NRPs) Related Pathological Conditions and Their Modulators

  2022cites this paper
• Comparative Proteomic Analysis of Liver Tissues and Serum in db/db Mice

  2022cites this paper
• An update on the interaction between COVID-19, vaccines, and diabetic kidney disease

  2022cites this paper
• Glyoxal-Lysine Dimer, an Advanced Glycation End Product, Induces Oxidative Damage and Inflammatory Response by Interacting with RAGE

  2021cites this paper
• ASSOCIATION BETWEEN ADVANCED GLYCATION END PRODUCTS AND INTAKE OF DIFFERENT TYPES OF BEVERAGES IN A HEALTHY POPULATION OF STUDENTS

  2021cites this paper
• Glomerular Endothelial Cell Crosstalk With Podocytes in Diabetic Kidney Disease

  2021cites this paper
• Neuropilin 1: A Novel Entry Factor for SARS-CoV-2 Infection and a Potential Therapeutic Target

  2021cites this paper
• BTT_A_307352 143..152

  2021cites this paper
• Diabetic Nephropathy and COVID-19: The Potential Role of Immune Actors

  2021influential citation
• AGE-Induced Suppression of EZH2 Mediates Injury of Podocytes by Reducing H3K27me3

  2020cites this paper
• The Development of Maillard Reaction, and Advanced Glycation End Product (AGE)-Receptor for AGE (RAGE) Signaling Inhibitors as Novel Therapeutic Strategies for Patients with AGE-Related Diseases

  2020cites this paper
• Foxc2 is essential for podocyte function

  2019cites this paper
• Anti-neuropilin-1 monoclonal antibody suppresses the migration and invasion of human gastric cancer cells via Akt dephosphorylation

  2018cites this paper
• Long-term expression of glomerular genes in diabetic nephropathy

  2018cites this paper
• Kidney, heart and brain: three organs targeted by ageing and glycation.

  2017cites this paper
• Effect of TongluoYishen formula on rearrangement of cytoskeleton of glomerular podocyte in diabetic nephropathy rats

  2017cites this paper
• Histamine Receptors as Drug Targets

  2017cites this paper
• Nicousamide protects kidney podocyte by inhibiting the TGFβ receptor II phosphorylation and AGE-RAGE signaling.

  2017cites this paper
• Methodological Approaches to Study Histamine Pharmacology in the Kidney: From Cell Culture and Cell Imaging to Functional Assays and Electron Microscopy

  2017cites this paper
• Neuropilin1 regulates glomerular function and basement membrane composition through pericytes in the mouse kidney.

  2017cites this paper
• Growth arrest specific 2-like protein 1 expression is upregulated in podocytes through advanced glycation end-products

  2016cites this paper
• Forkhead genes in adipocytes and podocytes

  2016cites this paper
• Semaphorin 3A serum levels are influenced by haemodialysis: What clinical significance?

  2015cites this paper
• Role of Neuropilin-1 in Diabetic Nephropathy

  2015cites this paper
• A Systems Biology Overview on Human Diabetic Nephropathy: From Genetic Susceptibility to Post-Transcriptional and Post-Translational Modifications

  2015cites this paper
• Der Einfluss von advanced glycation end-products auf die podozytäre Expression des nuklearen Inhibitors der Proteinphosphatase 1

  2014cites this paper
• Activation of the receptor for advanced glycation end products induces nuclear inhibitor of protein phosphatase-1 suppression.

  2014cites this paper
• A monoclonal antibody targeting neuropilin-1 inhibits adhesion of MCF7 breast cancer cells to fibronectin by suppressing the FAK/p130cas signaling pathway

  2014cites this paper
• δ-Opioid Receptor Activation Modified MicroRNA Expression in the Rat Kidney under Prolonged Hypoxia

  2013cites this paper
• Glycemic Memories and the Epigenetic Component of Diabetic Nephropathy

  2013cites this paper
• Erythropoietin ameliorates podocyte injury in advanced diabetic nephropathy in the db/db mouse.

  2013cites this paper
• Excess podocyte semaphorin-3A leads to glomerular disease involving plexinA1-nephrin interaction.

  2013cites this paper
• Angiotensin II Differentially Regulates Morg1 Expression in Kidney Cells

  2012cites this paper
• Neuropilins: expression and roles in the epithelium

  2012cites this paper
• Pathophysiology of the diabetic kidney.

  2011cites this paper
• Podocyte vascular endothelial growth factor (Vegf164) overexpression causes severe nodular glomerulosclerosis in a mouse model of type 1 diabetes

  2011cites this paper
• Advanced glycation end products inhibit adhesion ability of differentiated podocytes in a neuropilin-1-dependent manner.

  2011influential citation
• Impaired neurovascular repair in subjects with diabetes following experimental intracutaneous axotomy.

  2011cites this paper
• Gene Expression of Neuropilin-1 and Its Receptors, VEGF/Semaphorin 3a, in Normal and Cancer Cells

  2010cites this paper
• Insights to the genetics of diabetic nephropathy through a genome-wide association study of the GoKinD collection.

  2010cites this paper
• Advanced glycation end‐products and the kidney

  2010cites this paper
• Erythropoietin Protects Podocytes from Damage by Advanced Glycation End-Products

  2010cites this paper
• ExprEssence - Revealing the essence of differential experimental data in the context of an interaction/regulation net-work

  2010cites this paper
• Neuropilin-1 and neuropilin-2 are differentially expressed in human proteinuric nephropathies and cytokine-stimulated proximal tubular cells

  2009cites this paper
• Running Title: Podocyte MCP-1/CCR2 loop, motility, and albumin permeability

  2009cites this paper
• The monocyte chemoattractant protein-1/CCR2 loop, inducible by TGF-beta, increases podocyte motility and albumin permeability.

  2009cites this paper
• Advanced Glycation End Products Suppress Neuropilin-1 Expression in Podocytes by a Reduction in Sp1-Dependent Transcriptional Activity

  2009cites this paper